SAA’s 5th Annual Global Spondyloarthritis Summit

The Global Spondyloarthritis Summit is just one example of our ongoing commitment to empowering the SpA community, and we are proud to be able to offer access to this content – all at no charge.

ENCINO, Calif. (PRWEB)
May 03, 2023

As an integral component of its mission and ongoing commitment to providing programs to educate and empower the spondyloarthritis (SpA) community, the Spondylitis Association of America (SAA) will host its 5th Annual Global Spondyloarthritis Summit, May 5- 6, 2023. This year’s educational program provides attendees access to 12 presentations covering advanced and introductory topics such as treatment options, diet and nutrition, genetics, sleep and spondyloarthritis, gender differences, surgery recommendations, cannabis, cardiovascular disease, flares, and more. Free access to Summit presentations begins at 9 am PDT on Friday, May 5, 2023.

Spondyloarthritis is a complex disease with serious complications. Managing the disease’s symptoms remains a lifelong journey filled with physical and emotional hurdles. To provide the most relevant information to those impacted, an international advisory committee of patients and healthcare practitioners review the panel of experts, topics and content for the 2023 Summit. So, whether someone is newly diagnosed or has been living with the disease for years, all attendees can gain insights from sessions ranging from introductory-level presentations to more advanced topics. “We are thrilled this year’s Summit coincides with our 40th Anniversary,” said SAA CEO Cassie Shafer. “The Global Spondyloarthritis Summit is just one example of our ongoing commitment to empowering the SpA community, and we are proud to be able to offer access to this content – all at no charge,” Shafer added.

SAA is grateful to this educational program’s financial supporters, including our individual and corporate members, and our presenting supporters AbbVie and Novartis and Room Sponsor UCB.

To learn more about the Summit, visit: spondylitis.org.

About the Spondylitis Association of America

Since its founding in 1983, the Spondylitis Association of America has been the leading national nonprofit providing educational resources, connections, and critical support that people with spondyloarthritis need. SAA is committed to increasing awareness of the disease, providing information and support to patients and their families, and funding research to ultimately uncover a cure for the disease.

SAA has a wealth of information, educational materials, and resources for medical practitioners, the newly diagnosed, those seeking a proper diagnosis, and those already diagnosed and living with the disease.

###

Share article on social media or email:

“We developed the Voluson™ Expert 22 from the ground-up to re-invent ultrasound, taking into account the current and future needs of clinicians providing precision diagnosis” – Gerald Seifriedsberger, General Manager, Women’s Health Ultrasound, GE HealthCare.

LOS ANGELES (PRWEB)
May 03, 2023

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that it has selected GE HealthCare, a leading global precision health care innovator, as a winner in the 7th annual MedTech Breakthrough Awards program. The company was awarded “Best New Ultrasound Technology Solution” recognizing the breakthrough innovation of the Voluson™ Expert 22 Women’s Health ultrasound system.

Performing detailed exams with high-resolution can provide early insights into fetal health. By identifying fetal abnormalities earlier, clinicians can intervene sooner, plan for delivery, and potentially improve outcomes.

Both intuitive and customizable, the Voluson™ Expert 22 provides ultra-premium ultrasound imaging that increases exam speed and accuracy through its use of graphic-based beamformer technology and artificial intelligence (AI). The result is higher quality images and greater flexibility in workflow and imaging functions.

The Voluson™ Expert 22 features Lyric Architecture, which allows for more data and works in concert with specialized probe technology to unlock new imaging and processing power. This enables faster, sharper and clearer images and increased independence from body habitus (differing shape and size of the human body) and other difficult scanning conditions. By generating new levels of penetration, resolution, and frame rates to reveal fine anatomy in 2D/3D/4D with ease, the system delivers uniformity throughout the image with increased spatial and contrast resolution.

Clinicians can also make use of SonoLyst*, a virtual on-board tool that uses AI to automatically help identify fetal anatomy seen on standard views while enhancing efficiency by adding annotations and measurements. For quality assurance, SonoLyst can also be used to compare the image or view acquired to standard criteria helping ensure exam quality and consistency needed due to the shortage of skilled labor. Additionally, the system boasts Respond, a workflow enhancer that uses probe activation sensors to automatically initialize probes and presets when removed from the probe holder.

“Voluson™ Ultrasound products have a long-standing reputation of providing state-of-the-art technology for women’s health. We developed the Voluson™ Expert 22 from the ground-up to re-invent ultrasound, taking into account the current and future needs of clinicians providing precision diagnosis,” said Gerald Seifriedsberger, General Manager, Women’s Health Ultrasound, GE HealthCare. “We are therefore delighted to accept this award from MedTech Breakthrough, and pledge to continue to drive daily imaging efficiencies and innovate in women’s health.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and many more. This year’s program attracted more than 4,000 nominations from over 17 different countries throughout the world.

“Complex pregnancies demand advanced tools so clinicians can quickly and precisely diagnose or monitor a patient’s condition, and clinicians need a smart, intuitive medical ultrasound imaging system that can help them overcome workforce and training challenges. The breakthrough Voluson™ Expert 22 delivers on this need,” said James Johnson, managing director, MedTech Breakthrough. “With its unique features, clinicians can uncover critical answers sooner, discover key insights, and simplify complex cases for faster assessment, detection, and diagnosis. Congratulations to GE HealthCare on winning the ‘Best New Ultrasound Technology Solution” award for 2023.”

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.

Follow us on Facebook, LinkedIn, Twitter, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com/ for more information.

*SonoLyst incorporates the AI technology of Intelligent Ultrasound.

Share article on social media or email:

Capital Caring Health Tom Koutsoumpas and Chapters Health System Andrew Molosky

“We are thrilled to finalize the affiliation with Capital Caring Health, which for both organizations officially begin a new era in advanced illness care.” — Andrew Molosky, president and chief executive officer for Chapters Health System

FALLS CHURCH, Va. and TEMPLE TERRACE, Fla. (PRWEB)
May 03, 2023

Chapters Health System and Capital Caring Health announced today the finalization of their groundbreaking affiliation. The two organizations combined resources to support ongoing innovation and critical care expansion in the communities they each serve. Chapters Health is one of the nation’s premier not-for-profit, community-based healthcare organizations headquartered in Temple Terrace. Founded in 1977, and located in the nation’s capital, Capital Caring Health was, along with several other entities, one of the first in the nation to provide hospice and related care.

“For the past several years, Chapters Health has been on an aggressive and ambitious trajectory to change the way chronic illness management and end-of-life care is administered in our communities,” said Andrew Molosky, MBA, FACHE, CHPCA, president and chief executive officer for Chapters Health. “We are thrilled to finalize the affiliation with Capital Caring Health, which for both organizations officially begin a new era in advanced illness care.”

With totals of 4,000 employees and 3,000 volunteers combined, Chapters Health and Capital Caring Health now represent the largest, not-for-profit advanced illness and hospice care organizations in the nation among the nearly 4,700 hospice providers.

Tom Koutsoumpas, President and CEO of Capital Caring Health further stated, “Chapters Health and Capital Caring Health are changing the healthcare landscape by dramatically strengthening our combined not-for-profit missions. Together we provide the best possible outcomes for patients, families and our dedicated team members.”

With the combined resources of the Chapters Health System and Capital Caring Health, healthcare services will be provided to residents in 34 Florida counties, four Georgia counties, two Maryland counties, five Virginia counties along with five independent cities in the state and all eight wards of Washington D.C., allowing more than 100,000 lives to be touched annually.

“As we officially welcome the Capital Caring Health team into the Chapters Health family, we are excited to work in lock step with our shared mission to constantly elevate home and community-based, end-of-life care,” added Molosky.

About Chapters Health System

As a progressive leader and premier healthcare organization, Chapters Health System is dedicated to delivering innovative care throughout chronic illness progression and beyond. Since 1983 as a community-based, not-for-profit organization, Chapters Health has provided choices, education and guidance through its managed affiliates. All offerings are provided to improve the patient/family experience well in advance of end-of-life needs. In 2023, Chapters Health was named a Top Workplaces USA award-winner; in 2022, earned certified status for information security from HITRUST and for the fifth consecutive year was recognized as a great workplace in the Aging Services category by the independent analysts at the Great Place to Work® Institute. To learn more, visit http://www.chaptershealth.org, like us on Facebook or follow us on Twitter and LinkedIn.

About Capital Caring Health

Capital Caring Health is a not-for-profit, community-based organization founded in the nation’s capital in 1977. Capital Caring Health is one of the most experienced and respected providers of advanced illness, hospice and elder care services in the country. Our care for children with life – limiting disease is the largest on the East Coast. Additional services focus on the special care needs of veterans, and those with heart failure and end-stage lung disease. More than $3.0 million annually funds care for those who lack coverage or the necessary financial resources for services. Almost 90 cents of every dollar go to caring for patients and their families. Over the years, Capital Caring Health has provided hospice, palliative care, and counseling to nearly 120,000 patients and their families through our regional neighborhood network across Maryland, Virginia and Washington D.C.

Share article on social media or email:

The Chopin Law Firm LLC is an award-winning personal injury
firm in New Orleans, LA, backed by more than 100 years of combined experience and extensive legal resources.

“Our team remains dedicated to providing our clients with the highest level of legal representation, ensuring they receive the compensation they deserve.” – Owner and Managing Attorney of The Chopin Law Firm, Justin Chopin.

NEW ORLEANS (PRWEB)
May 03, 2023

The Chopin Law Firm, a respected and prominent personal injury law firm in New Orleans, Louisiana, has successfully secured a $12,550,000.00 settlement for their client and her family after a local hospital’s negligence in recognizing and treating her stroke. The substantial award will support the client’s family and ensure that she receives the best possible medical care.

This recent settlement is another testament to the firm’s expertise in handling medical malpractice cases. In 2015, founding partner Dick Chopin was trial counsel and obtained a $7,000,000 jury verdict in a medical malpractice case in New Orleans, Louisiana, involving the death of an 8-year-old girl. This verdict is believed to be the second-highest jury verdict in a medical malpractice case awarded to a single plaintiff at that time.

Now, attorneys Mike Letourneau and Justin Chopin led the recent case, diligently working together to achieve a favorable outcome for their client. Together they hired the best experts and spared no expense to ensure that the hospital and their insurance companies paid every penny their clients deserved. The Chopin Law Firm’s commitment to justice and client well-being is evident in their successful track record.

In light of the recent settlement, Justin Chopin said, “We’re proud to have helped our client and her family find some semblance of justice after the hospital’s negligence. Our team remains dedicated to providing our clients with the highest level of legal representation, ensuring they receive the compensation they deserve.”

In an era where medical malpractice cases are becoming increasingly complex, The Chopin Law Firm remains committed to staying up-to-date on the latest developments in the field. Their team of experienced attorneys is equipped with the knowledge and resources necessary to tackle even the most challenging medical malpractice cases.

With a focus on medical malpractice cases, The Chopin Law Firm continues to advocate for victims of negligence and achieve significant results on their behalf.

About The Chopin Law Firm:

The Chopin Law Firm is a well-respected personal injury firm in New Orleans, Louisiana, with over 100 years of collective experience. The firm handles a variety of cases beyond personal injury, including property damage and insurance claims, workers’ compensation, business and commercial litigation, and business disruption claims. They are rated AV® Preeminent by Martindale-Hubbell® and are licensed to practice in Louisiana, Texas, and Mississippi.

For more information, visit http://www.chopinlawfirm.com or call (504) 475-2429.

Share article on social media or email:

“Our mission is to empower patients to take charge of their health through accessible and affordable testing solutions. This 2023 MedTech Breakthrough Award is a testament to the hard work and dedication of our team in making that vision a reality” – Healthy.io chief technology officer, Ron Zohar.

LOS ANGELES (PRWEB)
May 03, 2023

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market, today announced that Healthy.io, the global leader in transforming the smartphone camera into a medical device, has been selected as the winner of the “Best In-Home Testing Solution” award in the 7th annual MedTech Breakthrough Awards program, recognizing the breakthrough innovation of Healthy.io’s Minuteful Kidney at-home test kits.

Healthy.io’s patented, smartphone-based technology allows patients to perform clinical-grade medical tests from the comfort of their own homes, using only their smartphones and a set of easy-to-use testing kits to detect early signs of kidney damage. The results are delivered to healthcare providers in real-time, enabling faster diagnosis and treatment, and reducing the need for unnecessary doctor visits. Healthy.io recently received FDA clearance for its breakthrough technology that can turn any smartphone into a clinical-grade medical device.

Healthy.io’s Minuteful Kidney at-home test kits exemplify the company’s impact on the industry. These urine tests can be completed anywhere using a patient’s smartphone camera to assess their albumin-to-creatine ratio (ACR)—a key indicator of chronic kidney disease (CKD). CKD can be fatal, and as it’s asymptomatic in its early stages, is commonly known as a ‘silent killer.’ Over 75 million Americans should complete an annual ACR test, but nearly 80% of them don’t because of various barriers to care.

“Our mission is to empower patients to take charge of their health through accessible and affordable testing solutions. This 2023 MedTech Breakthrough Award is a testament to the hard work and dedication of our team in making that vision a reality,” said Healthy.io chief technology officer, Ron Zohar. “Fighting kidney disease is a heavy burden on the U.S. healthcare system, costing it roughly $120 billion each year—Minuteful Kidney is helping address this problem. We are thrilled that MedTech Breakthrough is recognizing our innovative approach and success in addressing this challenge.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work, and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data, and many more. This year’s program attracted more than 4,000 nominations from over 17 different countries throughout the world.

“Healthy.io’s Minuteful Kidney is a breakthrough solution that is also redefining telehealth, as a bridge for healthcare providers to connect and engage with their patients beyond a video call,” said James Johnson, managing director, MedTech Breakthrough. “The seamless transference between at-home results and healthcare providers—created by Healthy.io’s breakthrough innovators—is vital to today’s digital world, increasing patient engagement for doctors and convenience for patients. We extend our sincerest congratulations to the entire Healthy.io team for a well-deserved 2023 MedTech Breakthrough Award.”

Minuteful Kidney has also transformed medical and clinical testing. Without the hassle of scheduling appointments and accounting for transportation, the clinical-grade medical device has increased accessibility in healthcare deserts, including rural and low-income areas. Lack of transportation bars 3.6 million Americans from receiving the healthcare they need, and at-home test kits like Minuteful Kidney resolve this issue by eliminating the need for transit. By increasing accessibility for patients and providers, Minuteful Kidney raised the percentage of at-risk people who get tested for CKD from 20 percent up to 50 percent, regardless of demographic and socio-economic differences.

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity, and more. For more information visit MedTechBreakthrough.com.

About Healthy.io

Healthy.io is a global leader in transforming the smartphone camera into a medical device. The company developed the first and only FDA-cleared, smartphone-powered home kidney

test. Healthy.io partners with leading health plans to integrate Minuteful Kidney™ across their

populations. For the first time, untested, at-risk members can now take the test in the privacy of their homes and receive instant results, thus closing care gaps and removing barriers associated with traditional lab testing. Minuteful Kidney™ is marketed commercially across the United States and the United Kingdom. Healthy.io has offices in Boston, London, and Tel Aviv.

Share article on social media or email:

Drew has the expertise, the temperament, and the proven success to make better maternal care a reality for mothers in a scalable and cost-effective way. He has the toolbox to position Babyscripts as the most widely-available, comprehensive virtual maternity care solution on the market.

WASHINGTON (PRWEB)
May 03, 2023

Babyscripts, the leading virtual care platform for managing obstetrics, today announced the appointment of Andrew Reeve as Executive Vice President of Revenue. In this role, Mr. Reeve will be responsible for accelerating Babyscripts’ strategic partnerships in payer and provider markets. Andrew will lead Babyscripts’ go-to-market strategy and functions driving market share, revenue growth, and customer engagement.

Mr. Reeve has more than two decades of experience and demonstrated success in driving growth for innovative companies, with over 15 years spent in the healthcare industry. Before joining Babyscripts, Andrew held the position of Chief Revenue Officer at Ultromics, an Oxford University spin-out focused on applying artificial intelligence to echocardiography for improved detection and risk-stratification of cardiovascular disease. As the lead US executive, Andrew built the sales, marketing, and customer success functions from scratch, establishing the company’s U.S. market presence and initial customer base. He assisted cardiology provider organizations in leveraging the latest and most innovative technologies for improved and earlier diagnosis of heart disease.

Previously, he served as Senior Vice President of Sales and Business Development at Collective Medical, where he led the build-out of the nations’ largest network for improved care collaboration across the healthcare continuum. As one of the company’s early employees joining in 2016, Andrew oversaw the company’s significant growth with U.S. healthcare providers and payers, culminating in the acquisition of Collective Medical by PointClickCare in December 2020.

“Babyscripts sees the tremendous opportunity for disruption and transformation in the maternity care space,” said Reeve. “Patients are beginning to expect RPM and digital capabilities as part of their provider selection process. Mothers are working. The number of physicians is declining, while demand for healthcare services is increasing. Babyscripts is targeting the important questions, like how can technology make providers more efficient? How can we make payers more helpful and timely? I’m thrilled to be joining them in their mission to drive change forward for mothers.”

“Babyscripts’ mission is to deliver the best in maternity care to women, specifically those most at-risk,” said Anish Sebastian, Co-founder and CEO at Babyscripts. “Drew has the expertise, the temperament, and the proven success to make that a reality for mothers in a scalable and cost-effective way. With a wealth of experience that spans Federal and State health, care collaboration, AI, and cardiology; he has the toolbox to position Babyscripts as the most widely-available, comprehensive virtual maternity care solution on the market.”

Andrew holds an MBA from the University of Florida, Warrington College of Business and a Bachelor of Science in Business Administration from Alfred University. With a strong background in sales and

business development, Andrew is committed to creating sustainable growth and leveraging innovation and technology to improve the cost and quality of healthcare in the US and globally.

About Babyscripts

Babyscripts is delivering a new model for prenatal and postpartum care that is transforming the way expectant mothers use technology to work with their healthcare providers. Since its inception in 2014, Babyscripts has been delivering the most-implemented mobile clinical solution for remote monitoring in pregnancy, with the mission to eliminate maternal mortality and improve access to care for all mothers. For more information on our virtual care solution and to request a demo, visit babyscripts.com.

Share article on social media or email:

Rich Gray, Area Vice President of Sales, Maxx Orthopedics

“We are very excited to welcome Rich to Maxx Orthopedics. Rich embraces our core philosophy of putting surgeons at the center of every decision we make, and I am confident he will help propel our business into new geographies,” says Farzin Khaghani, CCO of Maxx Orthopedics.

KING OF PRUSSIA, Pa. (PRWEB)
May 03, 2023

Maxx Orthopedics, Inc., a rapidly expanding global orthopedics device company, recently appointed Rich Gray as Area Vice President of Sales, West. In this roll, Mr. Gray will be responsible for all strategic sales growth initiatives for the organization in the western half of the US, including strengthening relationships with customers, increasing the distribution network, and expanding the company’s footprint.

“We are very excited to welcome Rich to Maxx Orthopedics. He has a proven track record of delivering growth and is a consummate professional. Rich embraces our core philosophy of putting surgeons at the center of every decision we make, and I am confident he will help propel our business into new geographies,” says Farzin Khaghani, CCO of Maxx Orthopedics.

Mr. Gray’s career in the orthopedic industry began in October 2000 as a sales representative for Smith and Nephew Orthopaedics. His passion and focus have helped fuel his career as he ascended to roles of increasing responsibility in sales leadership including Director of Sales for Ortho Development and West Area Vice President of Sales for NextStep Arthropedix.

Mr. Gray holds a BS in Exercise Physiology, Biomechanics and Kinesiology from California State University.

About Maxx Orthopedics

Maxx Orthopedics is the manufacturer of the Freedom Knee® System, Libertas® Total Hip System and Quick Recovery Solutions (QRS®). The company develops and markets innovative orthopedic medical devices worldwide with a focus on providing state-of-the-art implants and related solutions that best restore patient mobility while accommodating lifestyle, anatomical and economic needs. Find out more at http://www.maxxortho.com

Share article on social media or email: